beta-cell Smad2 null mice have improved beta-cell function and are protected from diet-induced hyperglycemia
Myth: "If I take more milligrams, I'll get better results." Fact: Higher doses do not always mean better results
Can Wegovy be frozen
This is a primary concern for anyone with a torn patella
The SELECT trial showed that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity and established cardiovascular disease, without requiring a diabetes diagnosis. The FLOW trial showed kidney benefits with semaglutide use in patients with type 2 diabetes and chronic kidney disease. Improvements in hard clinical outcomes like cardiac events, kidney disease, and death are commonly observed with GLP-1 use, and are due to both the direct effects of treating the obesity, and indirect effects of the medications themselves
Glauser, T.A., et al., Physician knowledge about and perceptions of obesity management